Literature DB >> 9167907

Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses.

M K Howett1, N D Christensen, J W Kreider.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9167907     DOI: 10.1016/s0738-081x(96)00166-6

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  6 in total

1.  Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique.

Authors:  A A McBride; A Dlugosz; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection.

Authors:  T M Kish; L R Budgeon; P A Welsh; M K Howett
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses.

Authors:  Jelizaveta Geimanen; Helen Isok-Paas; Regina Pipitch; Kristiina Salk; Triin Laos; Marit Orav; Tormi Reinson; Mart Ustav; Mart Ustav; Ene Ustav
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

4.  Differentiation of xenografted human fetal lung parenchyma.

Authors:  Jelena Pavlovic; Joanna Floros; David S Phelps; Brian Wigdahl; Patricia Welsh; Judith Weisz; Debra A Shearer; Alphonse Leure du Pree; Roland Myers; Mary K Howett
Journal:  Early Hum Dev       Date:  2007-06-06       Impact factor: 2.079

5.  Efficient intracellular assembly of papillomaviral vectors.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  The transcription map of human papillomavirus type 18 during genome replication in U2OS cells.

Authors:  Mart Toots; Andres Männik; Gaily Kivi; Mart Ustav; Ene Ustav; Mart Ustav
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.